Hotchkis & Wiley Capital Management LLC Lowers Stake in Humana Inc. (NYSE:HUM)

Hotchkis & Wiley Capital Management LLC lowered its stake in Humana Inc. (NYSE:HUM) by 12.6% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 505,342 shares of the insurance provider’s stock after selling 73,150 shares during the period. Hotchkis & Wiley Capital Management LLC’s holdings in Humana were worth $160,062,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of HUM. Creative Financial Designs Inc. ADV lifted its position in Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 61 shares in the last quarter. CarsonAllaria Wealth Management Ltd. increased its position in Humana by 111.4% in the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after buying an additional 39 shares during the last quarter. Atwood & Palmer Inc. bought a new stake in Humana during the third quarter valued at $29,000. Ashton Thomas Securities LLC purchased a new position in Humana in the 3rd quarter worth approximately $31,000. Finally, Your Advocates Ltd. LLP grew its stake in Humana by 81.8% in the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after purchasing an additional 45 shares during the period. Institutional investors own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on HUM. Sanford C. Bernstein upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 target price on the stock in a research report on Tuesday, October 8th. Stephens reaffirmed an “equal weight” rating and issued a $250.00 price target on shares of Humana in a research report on Wednesday, October 9th. Barclays lifted their price objective on Humana from $250.00 to $253.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 31st. Oppenheimer lowered their price objective on shares of Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a research note on Thursday, October 3rd. Finally, KeyCorp assumed coverage on shares of Humana in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. Twenty investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $315.86.

Humana Trading Down 1.1 %

Humana stock opened at $293.09 on Tuesday. The firm’s fifty day moving average price is $275.33 and its 200-day moving average price is $329.24. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $502.73. The stock has a market cap of $35.29 billion, a P/E ratio of 25.96, a PEG ratio of 2.34 and a beta of 0.53.

Humana (NYSE:HUM) last released its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The firm had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Equities research analysts forecast that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a yield of 1.21%. Humana’s dividend payout ratio is currently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.